Related references
Note: Only part of the references are listed.Circulating inflammation markers and prostate cancer
Henrik Ugge et al.
PROSTATE (2019)
Med4way: a Stata command to investigate mediating and interactive mechanisms using the four-way effect decomposition
Andrea Discacciati et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2019)
Association Between Antidiabetic Medications and Prostate-Specific Antigen Levels and Biopsy Results
Kerri Beckmann et al.
JAMA NETWORK OPEN (2019)
Fasting blood glucose, glycaemic control and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer
Teemu J. Murtola et al.
BRITISH JOURNAL OF CANCER (2018)
Role of C-Reactive Protein at Sites of Inflammation and Infection
Nicola R. Sproston et al.
FRONTIERS IN IMMUNOLOGY (2018)
Fasting blood glucose and risk of prostate cancer: A systematic review and meta-analysis of dose-response
A. Jayedi et al.
DIABETES & METABOLISM (2018)
Low Free Testosterone and Prostate Cancer Risk: A Collaborative Analysis of 20 Prospective Studies
Eleanor L. Watts et al.
EUROPEAN UROLOGY (2018)
A historical cohort study on glycemic-control and cancer-risk among patients with diabetes
R. Dankner et al.
CANCER EPIDEMIOLOGY (2018)
The Physical Activity Guidelines for Americans
Katrina L. Piercy et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
Meta-analysis of metabolic syndrome and prostate cancer
M. Gacci et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
No Association of Waist Circumference and Prostate Cancer in the Cancer Prevention Study II Nutrition Cohort
Victoria L. Stevens et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2017)
Prospective investigation of risk factors for prostate cancer in the UK Biobank cohort study
Aurora Perez-Cornago et al.
BRITISH JOURNAL OF CANCER (2017)
Hyperglycemia, tumorigenesis, and chronic inflammation
Shu-Chun Chang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2016)
Association between baseline serum glucose, triglycerides and total cholesterol, and prostate cancer risk categories
Rhonda Arthur et al.
CANCER MEDICINE (2016)
Cholesterol Levels in Blood and the Risk of Prostate Cancer: A Meta-analysis of 14 Prospective Studies
Liu YuPeng et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2015)
Dissecting the Association Between Metabolic Syndrome and Prostate Cancer Risk: Analysis of a Large Clinical Cohort
Bimal Bhindi et al.
EUROPEAN UROLOGY (2015)
UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age
Cathie Sudlow et al.
PLOS MEDICINE (2015)
Type 2 Diabetes: A Protective Factor for Prostate Cancer? An Overview of Proposed Mechanisms
Reza Rastmanesh et al.
CLINICAL GENITOURINARY CANCER (2014)
Mediation analysis in epidemiology: methods, interpretation and bias
Lorenzo Richiardi et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2013)
Effect of metabolic syndrome and its components on prostate cancer risk: Meta-analysis
K. Esposito et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2013)
The effects of metabolic conditions on prostate cancer incidence over 15 years of follow-up: results from the Olmsted County Study
Lauren P. Wallner et al.
BJU INTERNATIONAL (2011)
Prostate Cancer Risk in the Swedish AMORIS Study The Interplay Among Triglycerides, Total Cholesterol, and Glucose
Mieke Van Hemelrijck et al.
CANCER (2011)
Serum total and HDL cholesterol and risk of prostate cancer
Alison M. Mondul et al.
CANCER CAUSES & CONTROL (2011)
Low levels of apolipoprotein A-I and HDL are associated with risk of prostate cancer in the Swedish AMORIS study
Mieke Van Hemelrijck et al.
CANCER CAUSES & CONTROL (2011)
The Metabolic Syndrome and the Risk of Prostate Cancer under Competing Risks of Death from Other Causes
Birgitta Grundmark et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Blood pressure, body size and prostate cancer risk in the Swedish Construction Workers cohort
Tanja Stocks et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
The Relationship of Testosterone to Prostate-Specific Antigen in Men with Sexual Dysfunction
Giovanni Corona et al.
JOURNAL OF SEXUAL MEDICINE (2010)
Components of the metabolic syndrome and risk of prostate cancer: the HUNT 2 cohort, Norway
Richard M. Martin et al.
CANCER CAUSES & CONTROL (2009)
The Protective Effect of Diabetes Mellitus Against Prostate Cancer: Role of Sex Hormones
N. Baradaran et al.
PROSTATE (2009)
Insulin-like growth factors, their binding proteins, and prostate cancer risk:: Analysis of individual patient data from 12 prospective studies
Andrew W. Roddam et al.
ANNALS OF INTERNAL MEDICINE (2008)
Investigation, treatment and monitoring of late-onset hypogonadism in males
C. Wang et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Inflammation and insulin resistance
Carl de Luca et al.
FEBS LETTERS (2008)
Obesity, metabolic syndrome, and prostate cancer
Ann W. Hsing et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2007)
Prostate-specific antigen values in diabetic and nondiabetic US men, 2001-2002
David M. Werny et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
A meta-analysis of diabetes mellitus and the risk of prostate cancer
Jocelyn S. Kasper et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Novel insights into the implication of the IGF-1 network in prostate cancer
AG Papatsoris et al.
TRENDS IN MOLECULAR MEDICINE (2005)
Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis
AG Renehan et al.
LANCET (2004)
Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
JI Cleeman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Share Paper
